Evidence map›Paper›PMID 41948523›Full record

ReviewBreast cancer (Dove Medical Press)2026

Lipid Metabolism and Breast Cancer Therapy: An Integrative Literature Review.

Xiongmeiyu Gong, Danni Zhang, Zini Wen, Jvtao Zeng, Yao Tang, Junjie Deng, Yawen Bin

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Breast cancer (Dove Medical Press), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiongmeiyu Gong *Department of Breast and Thyroid Surgery, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421000, People's Republic of China.
Danni Zhang *Department of Breast and Thyroid Surgery, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421000, People's Republic of China.
Zini Wen *Department of Breast and Thyroid Surgery, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421000, People's Republic of China.
Jvtao ZengDepartment of Breast and Thyroid Surgery, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421000, People's Republic of China.
Yao TangDepartment of Pathology, Xiangtan Central Hospital, Xiangtan, Hunan 411000, People's Republic of China.
Junjie DengDepartment of Breast and Thyroid Surgery, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421000, People's Republic of China.
Yawen BinDepartment of Breast and Thyroid Surgery, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421000, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is the most common malignant tumor in women, and its incidence once surpassed lung cancer in 2020, threatening women's health. Despite recent advances in the diagnosis and treatment of breast cancer, some patients still develop distant metastases or local recurrence after receiving initial treatment, which leads to a poor prognosis, reduced overall survival, and decreased quality of life. Therefore, finding effective ways to further improve breast cancer outcomes is of great clinical importance. Breast cancer can be categorized into four molecular subtypes based on the expression levels of hormone receptor (HR), human epidermal growth factor receptor 2 (HER2), and Ki-67, and the therapeutic choices vary by molecular type. Disorders of lipid metabolism are among the most prominent metabolic alterations in cancer. In this paper, we will synthesize the roles played by lipid metabolism in different therapeutic treatments for breast cancer, and provide new ideas for using lipid metabolism regulation to improve the efficacy of breast cancer treatment.

Indexed as

breast cancerfatty acid oxidationimmunotherapylipid metabolismTNBCtumor microenvironment

Identifiers

PMID41948523
PMCPMC13050990

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.